Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 152,822 | 218,779 | 77,922 | 180,133 | 340,351 |
| Receivables | 606,157 | 482,325 | 367,577 | 260,881 | 324,451 |
| Inventories | 381,067 | 457,219 | 284,038 | 175,230 | 125,582 |
| TOTAL | $1,210,210 | $1,286,644 | $771,933 | $631,141 | $822,073 |
| Non-Current Assets | |||||
| PPE Net | 477,997 | 544,146 | 486,758 | 233,372 | 214,156 |
| Intangibles | 1,802,257 | 2,081,195 | 71,043 | 827,795 | 812,186 |
| Other Non-Current Assets | 175,426 | 440,751 | 12,155 | 130,710 | 74,072 |
| TOTAL | $2,455,680 | $3,066,092 | $569,956 | $1,191,877 | $1,100,414 |
| Total Assets | $3,665,890 | $4,352,736 | $1,341,889 | $1,823,018 | $1,922,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,479 | 21,449 | 89,171 | 17,719 | N/A |
| Accounts payable and accrued liabilities | 513,452 | 532,135 | 207,401 | 58,952 | 56,325 |
| Accrued Expenses | N/A | N/A | N/A | 244,653 | 270,436 |
| TOTAL | $550,406 | $553,850 | $296,883 | $321,324 | $326,761 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,609,046 | 2,630,598 | 1,355,274 | 813,545 | 424,595 |
| Other Non-Current Liabilities | 339,843 | 263,241 | 21,159 | 62,127 | 35,952 |
| TOTAL | $2,768,696 | $2,902,523 | $1,420,588 | $877,720 | $533,317 |
| Total Liabilities | $3,319,102 | $3,456,373 | $1,717,471 | $1,199,044 | $860,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 299,226 | 298,690 | 73,936 | 73,748 | 72,603 |
| Common Shares | 2,992 | 2,987 | N/A | 739 | 729 |
| Retained earnings | -377,880 | -20,920 | -382,785 | 98,192 | 570,223 |
| Other shareholders' equity | 114,710 | 383,858 | -1,359 | -8,013 | -10,620 |
| TOTAL | $346,788 | $896,363 | $-375,582 | $623,974 | $1,062,409 |
| Total Liabilities And Equity | $3,665,890 | $4,352,736 | $1,341,889 | $1,823,018 | $1,922,487 |